Filter
2953
Filtered Results: 2953
Text search:
Drug
Resistance
Featured
Recommendations
314
New Publications
746
Language
Document type
No document type
1607
Studies & Reports
469
Guidelines
464
Manuals
139
Strategic & Response Plan
108
Fact sheets
60
Training Material
52
Situation Updates
15
Infographics
15
Resource Platforms
9
Brochures
5
Online Courses
5
Videos
3
App
2
Countries / Regions
India
157
Global
103
South Africa
82
Kenya
79
Western and Central Europe
74
Ethiopia
61
Uganda
55
Tanzania
51
Africa
49
Nepal
48
Eastern Europe
47
Zambia
42
Nigeria
40
Latin America and the Carribbean
40
Liberia
37
Sierra Leone
34
Malawi
32
Namibia
32
Ghana
31
Philippines
31
Myanmar / Burma
31
Bangladesh
29
Asia
28
Rwanda
27
Cambodia
24
Lesotho
22
South–East Asia Region
22
Zimbabwe
20
Ukraine
19
Senegal
19
Russia
19
Indonesia
19
Botswana
14
Congo, Democratic Republic of
13
Cameroon
12
Mozambique
12
Colombia
11
Venezuela
10
Thailand
9
Syria
9
Albania
8
Burkina Faso
8
West and Central Africa
8
Middle East and North Africa
8
Eastern Europe and Central Asia
8
Eswatini/ Swaziland
8
Haiti
7
Germany
7
East and Southern Africa
7
Argentina
7
Vietnam
7
Pakistan
7
Tajikistan
6
China
6
Laos
6
Benin
5
Guinea
5
USA
5
Western Pacific Region
5
Georgia
5
El Salvador
4
Iran
4
Peru
4
Brazil
4
Sri Lanka
4
Sudan
4
Iraq
4
North Macedonia
3
Estonia
3
Afghanistan
3
Jordan
3
Paraguay
3
North America
3
Uruguay
3
Lebanon
3
Central African Republic
3
Mali
3
Bhutan
3
South Sudan
3
Somalia
3
Switzerland
2
Timor Leste/ East Timor
2
Mexico
2
Morocco
2
Armenia
2
Saudi Arabia
2
Gabon
2
France
2
Tunisia
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Nicaragua
2
Moldova
2
Yemen
2
Honduras
2
Libya
2
Ecuador
2
Madagascar
2
Guatemala
2
Serbia
1
Turkey
1
Gambia
1
Kazakhstan
1
Canada
1
Fiji
1
Congo-Brazzaville
1
Niger
1
Qatar
1
Italy
1
Dominican Republic
1
Guinea-Bissau
1
Turkmenistan
1
Jamaica
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
United Kingdom
1
Spain
1
Bolivia
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Egypt
1
Romania
1
Greece
1
Angola
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
1041
Clinical Guidelines
293
Public Health
129
Women & Child Health
83
Key Resources
74
Capacity Building
46
Pharmacy & Technologies
41
Annual Report MEDBOX
1
Toolboxes
TB
514
HIV
369
AMR
329
NTDs
122
Mental Health
114
Malaria
114
COVID-19
96
Pharmacy
74
Caregiver
50
Planetary Health
48
Rapid Response
40
NCDs
37
Ebola & Marburg
33
Global Health Education
33
Refugee
31
2.0 Rapid Response
24
Health Financing Toolbox
23
Polio
17
Conflict
14
Cholera
13
Disability
11
Natural Hazards
8
Zika
5
Specific Hazards
3
Social Ethics
3
Antimicrobial agents like antibiotics are essential to treat some human and animal diseases. Microbes, such as bacteria, can develop resistance to antimicrobials meaning that a drug such as an antibiotic is no longer effective in treating the infection. The development of resistance is caused by the...
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
Barbados currently has a rudimentary framework and capacity to address the issue of antimicrobial resistance. There however needs to be coordination of efforts and improvement in areas where gaps have been identified.Actions required include improved antibiotic stewardship in healthcare settings, pr...
This document outlines the concept and content of the WHO people-centred approach to addressing antimicrobial resistance (AMR) in the human health sector. The proposed approach recognizes and aims to address the challenges and health system barriers people face when accessing health services to prev...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...
This document provides practical guidance on planning and implementing next-generation sequencing (NGS) technology for characterization of Mycobacterium tuberculosis complex (MTBC) bacteria. The aim is to detect mutations associated with drug resistance in the context of a surveillance system for tu...
The Libyan national action plan has been aligned with WHO five objectives. Analysis of the current situation and addressing the gaps and the needs to reach the main goal “one health” approach involves several national sectors and actors, including human and veterinary health, agriculture and foo...
World malaria report 2025
recommended
Addressing the threat of antimalarial drug resistance. This year’s report spotlights the growing threat of antimalarial drug resistance. Partial resistance to artemisinin derivatives – the backbone of malaria treatments after failures of chloroquine and sulfadoxine-pyrimethamine – has now b...
World malaria report 2025. Excecutive Summary
recommended
New
Addressing the threat of antimalarial drug resistance. This year’s report spotlights the growing threat of antimalarial drug resistance. Partial resistance to artemisinin derivatives – the backbone of malaria treatments after failures of chloroquine and sulfadoxine-pyrimethamine – has now b...
Antimicrobial Resistance Surveillance and Research Network | This manual describes well accepted methods to carry out drug susceptibility testing on important gram positive and gram negative clinically relevant bacteria. Methods of specimen collection, transport, culture, anti-microbial drug suscept...
Antimicrobial resistance represents a big threat to public health. The Centers for Disease Control and Prevention (CDC) estimate that every year two million Americans are infected with a (multi-)drug resistant bacterium, resulting in 23,000 deaths. The WHO has repeatedly drawn attention to this majo...
WHO
Considering programmatic implications of rising levels of HIV drug resistance: finalizing the Global Action Plan
Webinars 12 13 Dec 2016
Antimicrobial resistance (AMR) is one of the world’s top 10 public health threats. The World Health Organization (WHO) in the African Region, using the Antimicrobial Stewardship assessment tool, has assessed Member States progress on strengthening national capacity need for effective implementatio...
Antibiotic Stewardship (AS) is a coordinated program that promotes the appropriate use of antimicrobials to improve patient outcomes, reduce microbial resistance, and decrease the spread of multi-drug resistant organisms. In clinical settings, stewardship activities focus on measuring and improving ...
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t...
Tuberculosis treatment failure results in increased risk of morbidity, drug resistance, transmission and mortality. There are few data about tuberculosis treatment outcomes in Burkina Faso. The current study investigated the factors associated with tuberculosis treatment failure in the central east ...
Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ...
Antimalarial chemotherapy is crucial for reducing morbidity, mortality, and drug resistance, and is the cornerstone of malaria control. Existing antimalarial drugs act at different stages of the parasite’s life cycle. These drugs range from classic agents such as chloroquine and quinine to newer a...
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i...
